Navigation Links
IRS Awards Cash Grant to Advanced Life Sciences Under the Qualifying Therapeutic Discovery Project
Date:11/3/2010

CHICAGO, Nov. 3, 2010 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced that the Company has been awarded a cash grant under the Qualifying Therapeutic Discovery Project which was created by Congress as part of the Patient Protection and Affordable Care Act of 2010. In July 2010, the Company applied for the grant to help fund the development of Restanza™, a novel once-daily oral antibiotic for the treatment of community acquired bacterial pneumonia (CABP).

(Logo:  http://photos.prnewswire.com/prnh/20080218/ALSLOGO)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20080218/ALSLOGO)

The tax credit is targeted to projects that show a reasonable potential to: (i) develop new treatments that address "unmet medical needs" or chronic and acute diseases; (ii) reduce long-term health care costs; (iii) represent a significant advance in finding a cure for cancer; (iv) advance U.S. competitiveness in the fields of life, biological, and medical sciences; or (v) create or sustain well-paying jobs, either directly or indirectly. The total award granted to the Company was $244,479.25 which represents the maximum allocated amount per qualifying project.

About Advanced Life Sciences

Advanced Life Sciences is a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer and respiratory diseases. The Company's lead candidate, Restanza™, is a novel once-a-day oral antibiotic in late-stage development for the treatment of respiratory tract infections including CABP and biodefense pathogens including anthrax, plague and tularemia. For more information, please visit us on the web at www.advancedlifesciences.com or follow us on twitter at http://twitter.com/advancedlifesci.

Forward-Looking Statements

Any statements contained in this press release that relate to future plans, events or performance are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  Forward-looking statements represent our management's judgment regarding future events.  The Company does not undertake any obligations to update any forward-looking statements whether as a result of new information, future events or otherwise.  Our actual results could differ materially from those discussed herein due to several factors including the success and timing of our clinical trials and our ability to obtain and maintain regulatory approval and labeling of our product candidates; our plans to develop and commercialize our product candidates; the loss of key scientific or management personnel; the size and growth of potential markets for our product candidates and our ability to serve those markets; regulatory developments in the U.S. and foreign countries; the rate and degree of market acceptance of any future products; the accuracy of our estimates regarding expenses, future revenues and capital requirements; our ability to obtain financing on terms acceptable to us; our ability to obtain and maintain intellectual property protection for our product candidates; the successful development of our sales and marketing capabilities; the success of competing drugs that become available; and the performance of third party collaborators and manufacturers.  These and additional risks and uncertainties are detailed in the Company's filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Advanced Life Sciences Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. 2010 Lasker Awards Honor Trailblazers in Medical Research and Clinical Care
2. Talecris Biotherapeutics GmbH Awards Winners of the 7th Annual European ALTA Research Fellowship at 2010 ERS Meeting
3. Octapharma Grants Program Awards First Research Grant to Rush University Medical Center
4. NeoStem Named Best Stem Cell Company in The New Economys 2010 Biotech Awards
5. Twelve Women Scientists Announced as Winners of Elsevier Foundation TWOWS Awards
6. 2010 Michael E. DeBakey Journalism Awards Announced
7. Medical Writer Rita Buckley Wins Awards for Excellence in Medical Communication
8. Knome Announces KnomeDISCOVERY Research Awards Program
9. Siemens/Talecris Win Best Partnership in the Outsourcing Excellence Awards
10. BIO-IT World Announces the Winners of its 2010 Best Practices Awards Program
11. Another Top 10 Pharmaceutical Company Awards Cardiac Safety Study to iCardiac
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2017)... NY (PRWEB) , ... July 13, 2017 , ... ... with only two spectrophotometer calibration standards. Blast forward seven years and now ... photometric accuracy, holmium oxide for wavelength accuracy, and resolution testing. ...
(Date:7/13/2017)... ... July 13, 2017 , ... Trinity ... and reusable medical supplies has chosen The Copley Consulting Group to implement and ... seeks to align its internal and backend operations to streamline efficiencies to meet ...
(Date:7/12/2017)... ... July 11, 2017 , ... Business is booming for ... cooking experiences. , Over the past few weeks, Lajollacooks4u has welcomed ... challenges. Founder and Chef Jodi Abel has also lead several Farmers Market ...
(Date:7/12/2017)... ... July 12, 2017 , ... Exact Diagnostics continues to ... In Vitro Diagnostic (IVD) use. Panels available include: Adenovirus, BKV, CMV, ... , The Exact Diagnostics Verification Panels may be used as calibrators to establish reference ...
Breaking Biology Technology:
(Date:5/6/2017)... , May 5, 2017 RAM ... announced a new breakthrough in biometric authentication based ... quantum mechanical properties to perform biometric authentication. These new ... semiconductor material created by Ram Group and its ... entertainment, transportation, supply chains and security. Ram Group ...
(Date:4/18/2017)... Inc., a global expert in SoC-based imaging and computing solutions, has ... features the company,s hybrid codec technology. A demonstration utilizing TeraFaces ® ... be showcased during the upcoming Medtec Japan at Tokyo Big Sight ... Las Vegas Convention Center April 24-27. ... Click here for an image of the ...
(Date:4/13/2017)... April 13, 2017 According to a new market ... Identity Analytics, Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, ... Market is expected to grow from USD 14.30 Billion in 2017 to ... of 17.3%. ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):